Considering that the in vitro results of STMN1 and BAD in colorectal treatment were inconsistent, our results suggested that Fenticonazole may not provide a new therapeutic action in colorectal cancer and that it needed more research to be introduced as an anti-cancer drug. This evidence concerns the gene STMN1 and colorectal cancer.